Financials in USD. Standardized financial statements.
A compact view of how Embla Medical hf. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $932.24M | $854.89M | $785.68M | $718.65M | $718.67M | $629.50M | $686.26M | $612.88M | $567.82M | $519.57M |
| Revenue Growth? | +9.0% | +8.8% | +9.3% | -0.0% | +14.2% | -8.3% | +12.0% | +7.9% | +9.3% | 0.0% |
| Cost of Revenue? | $389.88M | $354.64M | $331.29M | $310.71M | $297.60M | $268.94M | $274.43M | $240.05M | $226.42M | $204.17M |
| Gross Profit? | $542.35M | $500.25M | $454.39M | $407.94M | $421.07M | $360.56M | $411.84M | $372.83M | $341.40M | $315.40M |
| Gross Margin? | +58.2% | +58.5% | +57.8% | +56.8% | +58.6% | +57.3% | +60.0% | +60.8% | +60.1% | +60.7% |
| Operating Expenses? | $417.18M | $387.49M | $366.93M | $322.80M | $325.45M | $306.49M | $306.01M | $289.81M | $261.05M | $238.95M |
| Operating Income? | $125.17M | $112.75M | $87.46M | $85.14M | $95.62M | $54.07M | $105.83M | $83.02M | $80.35M | $76.45M |
| EBITDA? | $183.71M | $167.94M | $143.25M | $118.13M | $150.55M | $71.47M | $143.70M | $122.45M | $95.00M | $94.97M |
| Income Before Tax | $108.35M | $90.56M | $76.01M | $56.17M | $86.64M | $12.72M | $90.27M | $96.92M | $68.64M | $68.26M |
| Income Tax Expense | $24.38M | $21.60M | $17.21M | $12.96M | $20.98M | $4.80M | $21.39M | $17.10M | $11.07M | $17.38M |
| Net Income? | $83.65M | $68.28M | $58.39M | $42.51M | $63.99M | $6.21M | $66.04M | $79.75M | $57.56M | $50.91M |
| EPS? | $0.20 | $0.16 | $0.14 | $0.10 | $0.15 | $0.01 | $0.16 | $0.19 | $0.13 | $0.12 |
| Diluted EPS? | $0.20 | $0.16 | $0.14 | $0.10 | $0.15 | $0.01 | $0.16 | $0.19 | $0.13 | $0.12 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality